Inovise Medical, a privately held cardiac diagnostic company, has raised $12.5 million in new capital to support development of technology that combines electrical and sound information to evaluate cardiac conditions associated
Inovise Medical, a privately held cardiac diagnostic company, has raised $12.5 million in new capital to support development of technology that combines electrical and sound information to evaluate cardiac conditions associated with coronary artery disease, left ventricular hypertrophy, acute coronary syndrome, and heart failure. This latest round of financing, which was led by new investors MDS Capital and TAT Capital Partners, brings the total equity investment in the firm to $22 million. The company could release its first product later this year. Managers from Hewlett-Packard founded Inovise Medical in 1997.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).